Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans
- 1 January 2012
- journal article
- research article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 47 (1), 270-277
- https://doi.org/10.1016/j.ejmech.2011.10.053
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Structure‐Based Design, Synthesis, and Antifungal Activity of New Triazole DerivativesChemical Biology & Drug Design, 2011
- Mutational Analysis of Flucytosine Resistance in Candida glabrataAntimicrobial Agents and Chemotherapy, 2010
- Structural Basis of Human CYP51 Inhibition by Antifungal AzolesJournal of Molecular Biology, 2010
- Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans AssayPLOS ONE, 2009
- Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdomsBiochimica et Biophysica Acta (BBA) - General Subjects, 2007
- Use of a spectrophotometric bioassay for determination of microbial sensitivity to manuka honeyJournal of Microbiological Methods, 2006
- The role of antifungal susceptibility testing in the therapy of candidiasisDiagnostic Microbiology and Infectious Disease, 2004
- Mechanisms of Fungal ResistanceDrugs, 2002
- Interaction of Aflatoxin B1 with Cytochrome P450 2A5 and Its Mutants: Correlation with Metabolic Activation and ToxicityChemical Research in Toxicology, 1997
- Studies on azole-induced cell death inSaccharomyces cerevisiaeFEMS Microbiology Letters, 1994